Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
PHXM
Fundamentals

Phaxiam Therapeutics S.a.

PHXM

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
12 Months Change

Assets

65.53M
▲19.72M▲43.05%
6 Months Change

Liabilities

0.00
0.000.00%
-

Free Cash Flow

-31.85M
▲25.22M▲44.19%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2023-03-28
Form 20-F
ID: 0001624422-23-000007
2022-04-27
Form 20-F
ID: 0001624422-22-000014
2021-03-08
Form 20-F
ID: 0001624422-21-000013
2020-03-18
Form 20-F
ID: 0001564590-20-011602
2019-03-29
Form 20-F
ID: 0001564590-19-010079
2018-04-24
Form 20-F
ID: 0001193125-18-128812